The hedgehog signalling pathway is responsible for the embryonic patterning of a range of tissues, and it is now known that dysregulation of this pathway can result in the formation of several tumour types. This cascade is regulated at the cell surface by the opposing actions of the patched and smoothened molecules which together form a receptor complex for hedgehog. The discovery that inactivation of the human patched gene is responsible for familial and sporadic forms of basal cell carcinoma ®rmly established a role for dysregulation of hedgehog signalling in tumorigenesis. Other key members of this pathway have also been shown to be involved in tumour formation, as have more distal downstream targets of hedgehog signalling. Since it appears that tumorigenesis results from constitutive activation of hedgehog responsive genes, the identi®cation of novel downstream targets of hedgehog signalling in given cell types is likely to increase our understanding of the molecular processes underlying tumour formation.
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The hedgehog signalling pathway is one of the most fundamental signal transduction pathways in embryonic development, being responsible for patterning the developing neural tube, axial skeleton, limbs, lungs, skin, hair and teeth (Bellusci et al., 1997; Hardcastle et al., 1998; Marigo and Tabin, 1996; Riddle et al., 1993; St-Jacques et al., 1998) . Much of what is known of the function of this pathway has been derived from studies in Drosophila, and many of the key elements have been conserved from¯ies through to humans Hahn et al., 1996a) . Several of the putative downstream targets of hedgehog signalling have been implicated in tumorigenesis, and some of these are the subject of other review articles in this edition. However, it was the discovery that mutation of the gene encoding the receptor molecule patched is responsible for familial and sporadic forms of basal cell carcinoma (BCC) which provided direct evidence for involvement of the key regulatory members of this signalling pathway in tumour formation (Hahn et al., 1996b; Johnson et al., 1996) . Dysregulation of the hedgehog signalling pathway is the major determinant of BCC formation, as well as being involved in the development of several other tumour types. It appears that tumour formation results when mutation of regulatory genes leads to constitutive activation of downstream hedgehog responsive genes. This article will review the role of hedgehog signalling in tumorigenesis, concentrating on the proteins responsible for receiving and transmitting the hedgehog signal at the cell membrane. In addition, progress towards producing mouse models of NBCCS and associated tumours will be discussed.
Hedgehog signalling pathway
The hedgehog (hh) pathway was originally delineated in Drosophila, and its members are encoded by segment polarity genes which are responsible for determining the anterior-posterior orientation of developing structures in the Drosophila embryo and larva (NussleinVolhard and Wieschaus, 1980; Basler and Struhl, 1994; Rodriguez and Basler, 1997) . Epistatic relationships suggested that, in addition to hedgehog, other members of this pathway included patched, the serpentine membrane protein smoothened (smo; Alcedo et al., 1996; van den Heuvel and Ingham, 1996) , the kinesinlike protein costal-2 (cos-2; Sisson et al., 1997) , the serine/threonine kinase fused (fu; Preat et al., 1990) , the novel protein suppressor of fused (Monnier et al., 1998) , and the zinc ®nger transcription factor cubitus interruptus (ci; Orenic et al., 1990) . Initial studies of this signalling pathway focused on the hedgehog molecule whose expression de®nes the development of many embryonic and adult structures in both the¯y and vertebrates.
Hedgehog and its receptor complex Hedgehog is a secreted molecule which undergoes autocatalytic cleavage to give an active N-terminal fragment (Lee et al., 1992 (Lee et al., , 1994 Porter et al., 1995) which is modi®ed by addition of a cholesterol moiety at its C-terminus (Porter et al., 1996) . While there is only a single Drosophila hedgehog gene, three vertebrate homologues have been identi®ed, Sonic (Shh), Desert (Dhh), and Indian hedgehog (Ihh) (Echelard et al., 1993) . In vitro studies suggest that each of these proteins can act through the same signal transduction pathway, and that the dierent hedgehog genes regulate patterning of dierent organ systems by virtue of their unique expression pattern (Echelard et al., 1993; Marigo et al., 1996; Stone et al., 1996) . The most extensively studied of the vertebrate hedgehog genes is Shh which is expressed widely throughout the developing CNS, limb, lung, gut, teeth and hair-follicle (Bellusci et al., 1997; Hardcastle et al., 1998; Litingtung et al., 1998; Marigo and Tabin, 1996; Riddle et al., 1993; St-Jacques et al., 1998) . Dhh and Ihh are primarily involved in development of the germline and skeletal system respectively (Bitgood et al., 1996; Vortkamp et al., 1996) .
The molecule responsible for acting as a receptor for hedgehog at the cell surface was the subject of debate for some time. Epistatic studies in Drosophila identi®ed smoothened and patched as acting upstream of fused, suppressor of fused, costal-2 and cubitus interruptus in the signalling pathway. Both smoothened and patched are putative transmembrane proteins, either of which could potentially act as the hedgehog receptor. It was not until in vitro studies were undertaken using vertebrate patched and smoothened proteins that patched was shown to bind hedgehog directly and hence act as the hedgehog receptor (Stone et al., 1996; Marigo et al., 1996) .
Patched encodes a 12-pass transmembrane glycoprotein with two large extracellular domains and a smaller intracellular domain. While the protein is similar in structure to a channel protein, no transport function has been attributed to it despite studies of the possible tracking of Ca+, K+, Na+ and Cl7 (Marigo et al., 1996) . Interestingly however, ®ve of the membrane spanning domains of patched show homology with sterol sensing domains in several proteins involved in cholesterol homeostasis . These include the protein responsible for the neurovisceral lipid storage disorder Niemann-Pick C disease, HMG-CoA reductase and SREBP cleavageactivating protein (SCAP). The role of the sterol sensing domain of patched is yet to be determined, but it does not appear to be simply involved in targeting hedgehog to the appropriate part of the adjacent membrane, since a Sonic hedgehog construct encoding the N-terminal fragment which is not modi®ed by cholesterol is capable of inducing both oor plate cells and motor neurons in neural explants (Roelink et al., 1995) . It has been proposed that the response of target tissues to hedgehog is dependent on the detection of intracellular sterol levels by the sterol sensing domain (Cooper et al., 1998) . Recently a second patched gene was identi®ed in vertebrates, and while it appears to act in a similar manner to patched in vitro, its role in hedgehog signalling remains to be elucidated (Carpenter et al., 1998; Motoyama et al., 1998; Smyth et al., 1999; Takabatake et al., 1997) .
While patched has been shown to directly bind the hedgehog ligand, smoothened also has a role in reception and transduction of the hedgehog signal. This was determined following the ®nding that patched also interacts with smoothened, and that hedgehog, smoothened and patched can be immunoprecipitated in a single complex (Stone et al., 1996) . Smoothened, which is structurally similar to the family of serpentine G-protein coupled receptors, is responsible for triggering intracellular signalling and the subsequent activation of target genes. The current model for hedgehog signalling suggests that, in the absence of hedgehog, patched interacts at the membrane with smoothened, rendering it inactive. However when hedgehog binds to patched, the inhibition of smoothened signalling is released and downstream genes are transcriptionally upregulated ( Figure 1 ). While it is known that the two large extracellular loops of the patched molecule are required for binding of hedgehog , the domains of patched which are responsible for binding smoothened have yet to be elucidated, although these interactions do appear to be modulated by the extracellular N-terminus of smoothened (Murone et al., 1999) .
While we now have a plausible model for how the hedgehog signal is received at the cell surface, we are just beginning to identify the complex and diverse mechanisms which regulate intracellular components of hedgehog signalling.
From the membrane to the nucleus In Drosophila the cubitus interruptus (ci) gene encodes the transcription factor primarily responsible for the activation and repression of hedgehog target genes (Von Ohlen et al., Figure 1 The hedgehog signalling pathway based on what is known in Drosophila. In the absence of hedgehog (hh), the patched protein (ptc) inhibits signalling by smoothened (smo). Upon binding of hedgehog this repression is released leading to dissociation of a complex of segment polarity proteins normally associated with the microtubules (Fu-fused, Su(Fu)-suppressor of fused, cos-2-costa-2, ci-cubitus interruptus). In vertebrates the role of ci is achieved by complex interactions involving three Gli genes 1997). Mediation of the hedgehog signal by Ci is controlled at the post-translational level (Aza-Blanc et al., 1997). In cells not exposed to hedgehog signal fulllength Ci, which forms a complex with costal-2, fused and suppressor of fused at the microtubules, is cleaved to give a 75 kDa N-terminal fragment which is localized in the nucleus and appears to act as a transcriptional repressor. This processing of Ci is thought to be mediated by the phosphorylation of the full-length form of the protein (Chen et al., 1999) . In the presence of hedgehog, cleavage of Ci is inhibited, the microtubule complex is dissociated and activation of target genes results (Figure 1 ). This activation is thought to result from a combination of lifting of repression by Ci75 (Aza-Blanc et al., 1997), nuclear import of full-length Ci (Chen et al., 1999) and maturation of full-length Ci into a labile transcriptional activator (Ohlmeyer and Kalderon, 1998) . Suppressor of fused opposes the conversion of Ci into a transcriptional activator and hence acts as a negative regulator of signalling (Ohlmeyer and Kalderon, 1998) .
While not all components of the Drosophila microtubule complex have yet been shown to have vertebrate homologues, it is likely that a similar mechanism is responsible for regulating vertebrate signalling. The role of Ci is achieved in vertebrates by the three Gli genes (Gli1, 2 and 3), with the precise role of each of these being the subject of much debate. Recent evidence suggests that like ci, Gli genes, in particular Gli2 and Gli3, act as bipotential transcription factors possessing both activation and repression domains (Altaba et al., 1999; Dai et al., 1999; Sasaki et al., 1999) . It is proposed that Gli2 and Gli3 act as the major mediators of hedgehog signalling (Sasaki et al., 1999) , and when converted to their active forms they activate Gli1 at the transcriptional level (Dai et al., 1999; Sasaki et al., 1999) . Activation of hedgehog target genes is thought to result from the synergistic action of Gli1, 2 and 3. In an analogous situation to that seen in Drosophila, human suppressor of fused has been shown to inhibit transcriptional activation by Gli1, at least in part by sequestering it in the cytoplasm (Kogerman et al., 1999) .
Downstream targets of hedgehog signalling
In Drosophila, known downstream targets of hedgehog signalling include wingless (homologous to the vertebrate Wnt genes), decapentaplegic (a member of the TGFb superfamily most homologous to the vertebrate bone morphogenetic proteins (Bmps)), as well as patched itself (reviewed in Ingham, 1998) . While it is likely that members of these gene families will be activated by hedgehog signaling in the vertebrate system, other as yet unidenti®ed genes will undoubtedly be regulated by this pathway. In addition, the identity of target genes is known to be cell type and organ speci®c. For example, the closest vertebrate homologues of decapentaplegic, the Bmp2 and Bmp4 genes, while activated by hedgehog signalling in the developing limb (Bitgood and McMahon, 1995) appear to be unaected by loss of hedgehog in the hair follicle (St-Jacques et al., 1998) . Other examples include the hepatocyte nuclear factor 3b (HNF3b) which is regulated by hedgehog signalling exclusively in the neural tube where its expression in the¯oor plate is induced by Sonic hedgehog from the notochord (Roelink et al., 1995) .
Recently several other genes have been shown to be responsive to hedgehog signalling, and while they are likely to be involved in the regulation of the pathway, their precise role is yet to be determined. The ®rst of these, which has been termed hip (for hedgehog interacting protein), encodes a membrane glycoprotein which binds all three hedgehog proteins with similar anity to patched (Chuang and McMahon, 1999) . Like patched, Hip is transcriptionally activated by hedgehog signalling, and it has also been proposed to be a negative regulator of signalling (Chuang and McMahon, 1999) . Another gene shown to be responsive to hedgehog signalling in both the somites and limb buds is a member of a novel family of SOCS (suppressor of cytokine signalling) box-containing WDproteins and has been termed both WSB1 and SWIP-1 (Hilton et al., 1998; Vasiliauskas et al., 1999) . This gene is one of the earliest markers to respond to sonic hedgehog in the limb, but its role in the signalling pathway remains unclear (Vasiliauskas et al., 1999) .
It is the regulation and identity of the downstream target genes which is likely to determine the role of hedgehog signalling in tumorigenesis. In general tumorigenesis results from constitutive activation of these genes, and it will be essential to determine novel hedgehog target genes in speci®c tissues to more fully understand the molecular pathogenesis of the tumours associated with dysregulation of hedgehog signalling.
Hedgehog signalling in disease and tumorigenesis
Several components of the hedgehog pathway have been implicated in tumorigenesis and in dysmorphology syndromes. Heterozygous mutation of sonic hedgehog is responsible for a subset of familial holoprosencephaly, a defect of the forebrain and midface (Roessler et al., 1996) . Similarly, Gli3 has been implicated in three distinct developmental syndromes all of which are characterized by limb abnormalities (Kang et al., 1997; Radhakrishna et al., 1997; Vortkamp et al., 1991) . In terms of tumour phenotypes, Gli1 was ®rst identi®ed by and named for its involvement in glioma formation (Kinzler et al., 1988) , and Wnt1 is known to be involved in murine mammary tumorigenesis (Nusse et al., 1990) . These genes, along with the Smad genes which mediate TGFb signalling and are involved in the formation of a range of tumour types, are the subject of other reviews in this edition. However, it was the discovery that patched is mutated in both familial and sporadic forms of basal cell carcinoma which ®rmly established this pathway as a major determinant of human cancer and disease.
Patched and nevoid basal cell carcinoma syndrome The human patched gene (PTCH) was ®rst implicated in tumorigenesis when it was shown to be mutated in the autosomal dominant cancer predisposition syndrome nevoid basal cell carcinoma syndrome or Gorlin's syndrome (Hahn et al., 1996b; Johnson et al., 1996) . NBCCS is characterized by a predisposition to a range of tumour types, most notably basal cell carcinoma, but also medulloblastoma, ovarian ®broma, meningioma, ®brosarcoma, rhabdomyosarcoma and cardiac ®broma (Gorlin, 1995; Shanley et al., 1994) . In addition to cancer predisposition, NBCCS is also associated with a range of developmental abnormalities including skeletal defects, dyskeratotic pitting of the hands and feet, progressive intracranial calci®cation, craniofacial anomalies and limb deformities including poly and syndactyly (Gorlin, 1995) . Many of these anomalies can now be correlated with the role of hedgehog signalling in patterning diverse structures during embryonic development, and it is thought that most of these developmental defects are due to haploisufficiency of the patched protein (Hahn et al., 1996b) . This is supported by the ®nding that by far the majority of PTCH mutations (480%) in the germline of NBCCS individuals result in truncation of the protein and are therefore likely to represent null mutations . The tumours in NBCCS individuals are likely to arise with inactivation of the remaining PTCH allele in a given cell type, consistent with PTCH acting as a tumour suppressor gene. The ®nding of PTCH mutations in a proportion of sporadic BCCs, in many cases with both alleles inactivated by either mutation or loss of heterozygosity , supports this putative function. Since the initial discovery of PTCH mutations in NBCCS and BCCs, the role of members of the patched/hedgehog signalling pathway in the pathogenesis of a range of tumour types has been the subject of intensive study.
Patched and BCCs
BCCs are common non-melanocytic skin tumours resulting from loss of growth control in keratinocytes. While BCCs rarely metastasise they are locally invasive and can in®ltrate underlying dermis and bone if left untreated (Weedon, 1991) . The site of origin of these tumours remains a matter of some contention, although their keratin expression pro®les and occasional pilosebaceous dierentiation suggest that they may arise from the hair follicle (Markey et al., 1992) , consistent with the expression of patched in this structure (Figure 2) .
Over-expression of both PTCH Unden et al., 1997; Wolter et al., 1997) and GLI1 (Dahmane et al., 1997) has been reported in BCCs, indicating dysregulation of hedgehog signalling in a high proportion of these tumours. The estimated frequency of PTCH mutations in sporadic BCCs ranges from 12 ± 38%, although in all cases this may represent an underestimate based on the mutation detection procedures employed (Aszterbaum et al., 1998b; Unden et al., 1997; Wolter et al., 1997) . In addition to mutations in the PTCH gene, loss of heterozygosity of markers on the region of chromosome 9q encompassing PTCH is observed in upwards of 50% of BCCs (Gailani et al., 1992) . Like NBCCS germline mutations, the majority of PTCH mutations in BCCs result in premature protein termination . In addition, many of the mutations detected in sporadic BCCs are C?T substitutions at dipyrimidine sites, indicating a role for ultraviolet-B irradiation in their genesis . In the most extensive analysis of PTCH mutations in sporadic BCCs to date, it was found that seven out of 16 mutations detected were of this type, and all tumours with such mutations had been removed from sun-exposed sites of the body . However, there is evidence from epidemiological data that factors other than sun exposure may be involved in BCC induction (Scotto et al., 1996) , with one such factor being the trivalent form of inorganic arsenic (Nakjang and Kullavanijaya, 1994; Tay and Seah, 1975; Wong et al., 1998; Yeh, 1973) . It Figure 2 Patched is expressed in the developing hair follicle. Whole amount in situ analysis of patched expression in a 15.0 dpc mouse embryo (a and b) . The probe used has been described previously (Hahn et al., 1996a) has yet to be shown de®nitively if these other agents contribute to BCC formation through mutation of the PTCH gene. In addition to sporadic BCCs and those associated with NBCCS, PTCH mutations have recently been identi®ed in BCCs associated with xeroderma pigmentosum (XP), a rare autosomal recessive disorder characterized by hyperphotosensitivity and predisposition to skin cancer (Bodak et al., 1999) . Individuals with XP are de®cient in the repair of UV-induced DNA lesions, and the proportion of BCCs with UV-speci®c mutations was found to be higher in those tumours derived from XP patients than in sporadic BCCs.
Smoothened and BCCs
Given that constitutive activation of smoothened is likely to upregulate transcription of hedgehog target genes in the same way as patched inactivation, it is not surprising that activating mutations in the smoothened gene have been detected in 10 ± 20% of sporadic BCCs (Lam et al., 1999; Reifenberger et al., 1998; Xie et al., 1998) . In particular one common mutation (Trp535Leu) in the seventh transmembrane domain of smoothened has been detected in several independent studies in up to 20% of BCCs (Lam et al., 1999; Xie et al., 1998) . In contrast to wild-type smoothened, the mutant form has been shown to result in constitutive smoothened signalling in an in vitro focus forming assay and in transgenic mice (Xie et al., 1998) . In vitro studies assessing activation of a Gli1 reporter construct have subsequently been used to identify which regions of the smoothened protein interact with patched and which are involved in signalling (Murone et al., 1999) . Consistent with some of the mutations observed in BCCs, the third intracellular loop and the seventh transmembrane domain were shown to be important in activation of signalling. Modelling of the Trp535Leu smoothened mutation, as well as a second mutation (Arg562Gln) in the C-terminus, leads to constitutive signalling of the protein in a manner which is not repressed by patched. The interactions of patched and smoothened were found to be mediated primarily through the cysteine rich N-terminus of smoothened, but to date no mutations in this region have been found in BCCs (Murone et al., 1999) .
Since hedgehog itself is primarily responsible for activation of this pathway, it is feasible that it also may be mutated in associated tumours, a premise supported by the ®nding that transgenic mice overexpressing Sonic hedgehog develop BCC-like skin lesions . Accordingly, a single recurrent mutation in Sonic hedgehog was initially reported in a range of tumour types including BCC , but failure of other workers to detect this mutation suggests that it is extremely rare (Reifenberger et al., 1998; Wicking et al., 1998) .
Taken together, inactivation of PTCH or oncogenic activation of smoothened occurs in a large proportion of BCCs, suggesting that dysregulation of hedgehog signalling is a requirement for BCC formation. Although it has previously been suggested that patched is the gatekeeper gene for BCC formation (Sidransky, 1996) , it may be more accurate to regard the entire hedgehog signalling pathway as the BCC gatekeeper. The term gatekeeper was coined by Kinzler and Vogelstein (Kinzler and Vogelstein, 1996) to describe genes which must be inactivated or activated to give rise to a particular type of tumour. While mutations in the p53 tumour suppressor gene have been described in 50% of BCCs (Zeigler et al., 1993) , these would be considered insucient to cause neoplasia without dysregulation of hedgehog signalling.
Dysregulation of hedgehog signalling in other tumour types Mutations in genes of the hedgehog signalling pathway have also been described in a range of tumours other than BCCs. In keeping with the predisposition of NBCCS patients to developing the childhood brain tumour medulloblastoma, mutations of both PTCH and smoothened have been detected in sporadic medulloblastomas and other primitive neuroectodermal tumours (Pietsch et al., 1997; Rael et al., 1997; Reifenberger et al., 1998; Vorechovsky et al., 1997a; Wolter et al., 1997) . NBCCS patients develop the desmoplastic histological subtype of medulloblastoma, and while one study reported PTCH mutations exclusively in this subtype (Pietsch et al., 1997) , mutations in classic medulloblastomas have also been described (Wolter et al., 1997) . In all cases, the incidence of mutations in these tumours was significantly less than that observed in BCCs, indicating it is likely that only a subset of these neoplasias are caused by mutations in PTCH or other members of the hedgehog signalling pathway. This notion is also supported by the frequency of loss of heterozygosity of the PTCH locus in medulloblastomas which is reduced when compared to BCCs (Pietsch et al., 1997) . It is also possible that PTCH2 may play a minor role in the pathogenesis of medulloblastoma since a screen for mutations in a large collection of medulloblastomas revealed a single protein truncating mutation (Smyth et al., 1999) .
Other tumours which carry PTCH mutations include the benign skin lesions tricoepitheliomas (TEs), esophageal squamous cell carcinomas and transitional cell carcinomas of the bladder (Vorechovsky et al., 1997b; Maesawa et al., 1998; McGarvey et al., 1998) . In addition, although mutations in PTCH are yet to be demonstrated in rhabdomyosarcomas, mice heterozygous for a null allele of patched develop this soft tissue tumour of the muscle at a high frequency (Hahn et al., 1998) . Since this tumour is also found at an increased incidence in NBCCS individuals, it is likely that this pathway plays a role in its pathogenesis.
Mouse models of NBCCS and associated tumours
The creation of mouse models of human disease by gene targeting or transgenic technology provides a powerful tool for the functional dissection of the disease phenotype. To date a range of mouse models have been produced by manipulation of members of the hedgehog signalling pathway. This section will focus on those animals which represent models for NBCCS and tumours associated with dysregulation of hedgehog signalling.
Patched null mutants To date two independent groups have generated patched null mice by targeted disruption of the patched gene (Goodrich et al., 1997; Hahn et al., 1998) . As would be expected from inactivation of such a developmentally important gene, homozygous Hedgehog signalling and cancer C Wicking et al null animals died during embryogenesis. However, in both cases the heterozygous mice showed a subset of both the developmental and neoplastic features associated with NBCCS. The ®rst patched null mutant to be produced involved inactivation of patched by replacement of part of exon one and the entire exon two by a lacZ/neo cassette, an insertion which results in removal of the primary start codon and deletion of transmembrane domain 1 (Goodrich et al., 1997) . The second was generated by the replacement of exons six and seven of patched with a neomycin cassette (Hahn et al., 1998) . In both cases homozygous mice die around 9.0 dpc by which stage failure of neural tube closure was evident. The heterozgous mice varied in phenotype between the two null alleles, though in both cases they displayed the generalized overgrowth and limb deformities characteristic of NBCCS.
Heterozygous animals displayed a tumour phenotype at a stage and frequency which would suggest that, unlike a classical tumour suppressor gene, somatic inactivation of the remaining allele was not occurring in all tumours. Heterozygotes for both null alleles developed medulloblastoma like lesions, this being seen at a particularly high frequency and young age in the Ptc +/neolacZ12 mice (Goodrich et al., 1997) . These mice also developed BCC-like skin tumours as adults, a feature which was enhanced by exposure to UV or cesium irradiation (Aszterbaum et al., 1998a) . The Ptc +/neo67 animals also developed rhabdomyosarcomas (RMS), a soft tissue tumour of the muscle which is seen in a small proportion of NBCCS patients (Hahn et al., 1998) . The dierence in phenotype between these null mice is likely to result from genetic background dierences, since even within the same null allele the percentage of mice that developed rhabdomyosarcomas varied on dierent mouse backgrounds (Hahn et al., 1998) . Genetic background eects are also likely to contribute to the wide variation in neural defects seen in transgenic mice overexpressing patched in the neural tube (Goodrich et al., 1999) . The contribution of genetic background to phenotype closely parallels the situation in humans where the phenotype of NBCCS individuals varies widely despite a predominance of truncating mutations which in most cases are presumed to be null alleles .
Overexpression of Sonic hedgehog and smoothened: Given the opposing actions of patched compared to hedgehog and smoothened at the cell membrane, overexpression of hedgehog or smoothened would be predicted to result in a similar phenotype to inactivation of patched. In an attempt to produce a transgenic mouse model of BCC formation, Oro and co-workers ectopically expressed full-length Sonic hedgehog under the control of the Keratin 14 (K14) promoter . K14 is expressed as early as 9.5 dpc in many epithelial tissues and in skin in both follicular and interfollicular cells (Byrne et al., 1994) . Although these animals died either peri-or postnatally, BCC-like epidermal proliferations were evident, as were a number of NBCCS-like features including limb anomalies reminiscent of polydactyly. In a similar fashion, a transgenic human tissue model of BCC was developed by regeneration of human skin on immune de®cient mice following retroviral transduction of human keratinocytes with Sonic hedgehog (Fan et al., 1997) .
It is assumed that the Sonic hedgehog models of BCC described above result from constitutive activation of smoothened signalling. While overexpression of wild type smoothened did not result in a tumour phenotype, ectopic expression of an activated smoothened gene under the control of the Keratin-5 promoter resulted in a microscopic skin phenotype consistent with BCCs, although no developmental anomalies were noted (Xie et al., 1998) . The smoothened gene in this case carried the Trp535Leu missense mutation observed in up to 20% of BCCs (Lam et al., 1999; Xie et al., 1998) . The absence of developmental anomalies in these mice ®ts with restricted expression in the skin of a membrane bound protein, while these anomalies in the K14-Shh mice may result from diusion of ectopically expressed Sonic hedgehog.
The mouse models outlined above provide a framework within which to dissect the contribution of hedgehog signalling to tumorigenesis at the molecular level. Combined with analyses of human tumours and in vitro approaches, a model for the role of this pathway in tumorigenesis is emerging. However, it is the discovery of novel hedgehog responsive target genes in given cell types which is likely to provide the ®nal link to how dysregulation of hedgehog signalling results in the neoplastic phenotype.
